Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment
Xinjia Du1, Jiahua Liu1, Jingfang Zhou1
1Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Background:
Microvascular obstruction (MVO) develops in approximately 50% of patients with ST-segment elevation myocardial infarction (STEMI) after undergoing percutaneous coronary intervention (PCI). MVO is strongly linked to inflammation, myocardial fibrosis, and adverse clinical outcomes. Soluble suppression of tumorigenicity 2 (sST2) serves as a biomarker for inflammation and myocardial fibrosis. Yet, the correlation between sST2 and MVO in STEMI patients has not been fully elucidated. This study attempts to evaluate the association between sST2 levels and MVO in STEMI patients following pPCI.
Methods:
In this retrospective study, 315 STEMI patients who underwent pPCI at the Affiliated Hospital of Xuzhou Medical University between June 2018 and August 2023 were included. Cardiac magnetic resonance imaging (CMR) was used to assess the characteristics of myocardial infarction and microvascular obstruction (MVO), while sST2 levels were measured upon admission.
Results:
The median time for completion of CMR after hospitalization was 5 (4, 6) days. Multivariate regression analysis showed that sST2 (OR 1.01, 95% CI 1.01-1.02, p < 0.001), peak high-sensitivity troponin T (OR 2.40, 95% CI 1.66-3.47, p < 0.001), peak high-C-reactive protein (OR 1.01, 95% CI 1.01-1.02, p < 0.001), left ventricular ejection fraction (OR 0.93, 95% CI 0.89- 0.98, p = 0.009) and age (OR 1.03, 95% CI 1.01- 1.05, p = 0.042)were independently associated with MVO.
Conclusion:
sST2 is associated with MVO after pPCI in STEMI patients. Incorporating soluble ST2 (sST2) into the risk model for MVO leads to significant improvement.
Insights
Soluble suppression of tumorigenicity 2 (sST2) is linked to microvascular obstruction (MVO) in ST-elevation myocardial infarction (STEMI) patients post-percutaneous coronary intervention. Including sST2 improves risk prediction for MVO.
Area of Science:
- Cardiology
- Biomarkers
- Myocardial Infarction Research
Background:
- Microvascular obstruction (MVO) affects 50% of ST-elevation myocardial infarction (STEMI) patients after percutaneous coronary intervention (PCI).
- MVO correlates with inflammation, fibrosis, and poor clinical outcomes.
- Soluble suppression of tumorigenicity 2 (sST2) indicates inflammation and fibrosis, but its role in STEMI-related MVO is unclear.
Purpose of the Study:
- To investigate the association between sST2 levels and MVO in STEMI patients undergoing primary PCI (pPCI).
- To determine if sST2 can enhance risk stratification for MVO.
Main Methods:
- Retrospective analysis of 315 STEMI patients who underwent pPCI.
- Cardiac magnetic resonance imaging (CMR) assessed MVO and myocardial infarction characteristics.
- Serum sST2 levels were measured upon admission.
Main Results:
- Multivariate analysis identified sST2 as an independent predictor of MVO (OR 1.01, p<0.001).
- Other independent predictors included peak high-sensitivity troponin T, peak C-reactive protein, left ventricular ejection fraction, and age.
- sST2 levels were significantly associated with the presence of MVO.
Conclusions:
- sST2 is significantly associated with MVO in STEMI patients post-pPCI.
- Integrating sST2 into risk models improves the prediction of MVO.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
The Tumor Microenvironment
